News About: Pharm. Industry
Rapid adoption of AI in developing new drugs ahead of Fourth Industrial Revolution
Ahead of the Fourth Industrial Revolution, Korean and foreign pharmaceutical companies are quickly moving forward to utilize artificial intelligence(AI) into developing new drugs. The trend has been highlighted in maj...
Sanofi eliminates a series of existing client distribution companies in Boehringer’s OTC business
It was told as Sanofi acquires the Boehringer Ingelheim’s OTC business, Sanofi stopped having businesses with a number of its existing client pharmaceutical distribution.
Because the distribution companies whose busi...
“It is not allowed to provide indirect rebates using support for foreign symposiums”
The pharmaceutical industry stressed importance of following the fair trade agreement and law by introducing examples of indirect provision of rebates using support for doctors on foreign symposium.
It basically mean...
“We’ll exclude unethical companies in certifying innovative pharmaceutical company”
The Ministry of Health and Welfare(MOHW) will tighten social responsibilities and ethical standards on innovative pharmaceutical companies.
In response to a recent criticism “It is irrational to provide preferential ...
Hanmi Pharm acquires approval of hypertension/hyperlipidemia treatmentHanmi Pharm(CEO Jong-Soo Woo, Sae-Chang Kwon) announced on the 17th that ‘Amosartan Q,’ a 3-substance combination drug with 2 antihypertensive substances and 1 anti-hyperlipidem...
|
Would it be possible for small pharmas to conduct co-R&D?
Chairman Yong-Joon Jo(CEO/President of Dongkoo Bio&Pharma) at the Korea Pharmaceutical Ind. Coop., which currently has approximately 100 medium and small pharmaceutical companies as its member, said at an interview wi...
Dong-A Pharm Bacchus’s manufacturing performance of KRW 223.7 billion‘Bacchus,’ a Dong-A Pharm’s energy drink, was known to record a manufacturing performance of KRW 232.7 billion last year.
According to the quasi drug manufacturing performance ...
|
Novartis, “We made payments, but never understood what RTM for”While people are paying interests in whether Novartis shared information internally, it was hard to check clear facts even at examination of a witness from its anticancer depart...
|
Jeil Pharmaceutical acquires European EDQM approval for ‘cephalosporin’ ingredientJeil Pharmaceutical(CEO/President Suk-Jae Sung) announced ‘cefpodoxime’ manufactured at the Baekam Factory’s ‘cephalosporin’ manufacturing facility located in Cheoin-gu, Yongin-...
|
Soom-to-be-expired medicines are also distributed due to manufacturing suspension
It was observed pharmaceutical products soon to be expired have been distributed to the market as pharmaceutical companies have continuously caused temporary out-of-stock and manufacturing suspension. Thus, returning ...
